We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Elective mergery

15 June 2016 By Jeffrey Goldfarb

AmSurg and Envision are combining in a $10 bln stock deal with each owning roughly half. They’re keeping two headquarters and yet still expect $100 mln of synergies, including “meaningful” ones from new revenue. It’s a dubious proposition that seems mostly like empire-building.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)